| FGF7 and FGF10 Promote Fate Transition of Human Epidermal Cell-derived Organoids to an Eccrine Gland Phenotype. | FGF7 and FGF10 Promote Fate Transition of Human Epidermal Cell-derived Organoids to an Eccrine Gland Phenotype.
Zhao J, Zhang L, Zhang Y, Cao M, Wang C, Hu A, Cao L, Luo Q, You Z, Ma X, Gong L, Zhang C, Li H., Free PMC Article | 09/17/2024 |
| FGF10 attenuates allergic airway inflammation in asthma by inhibiting PI3K/AKT/NF-kappaB pathway. | FGF10 attenuates allergic airway inflammation in asthma by inhibiting PI3K/AKT/NF-κB pathway.
Peng W, Song Y, Zhu G, Zeng Y, Cai H, Lu C, Abuduxukuer Z, Song X, Gao X, Ye L, Wang J, Jin M. | 12/6/2023 |
| FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells. | FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells.
Oeurn K, Jusakul A, Jaidee R, Kukongviriyapan V, Senggunprai L, Prawan A, Kongpetch S., Free PMC Article | 06/30/2023 |
| Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis. | Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis.
Jiang T, Hu W, Zhang S, Ren C, Lin S, Zhou Z, Wu H, Yin J, Tan L., Free PMC Article | 10/8/2022 |
| FGF10 promotes cardiac repair through a dual cellular mechanism increasing cardiomyocyte renewal and inhibiting fibrosis. | FGF10 promotes cardiac repair through a dual cellular mechanism increasing cardiomyocyte renewal and inhibiting fibrosis.
Hubert F, Payan SM, Pelce E, Bouchard L, Sturny R, Lenfant N, Mottola G, Collart F, Kelly RG, Rochais F. | 10/1/2022 |
| Deletion of the last two exons of FGF10 in a family with LADD syndrome and pulmonary acinar hypoplasia. | Deletion of the last two exons of FGF10 in a family with LADD syndrome and pulmonary acinar hypoplasia.
Wade EM, Parthasarathy P, Mi J, Morgan T, Wollnik B, Robertson SP, Cundy T., Free PMC Article | 04/23/2022 |
| FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia. | FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia.
Ling Y, Du Q. | 02/5/2022 |
| Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas. | Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas.
Tomita H, Tanaka K, Hirata A, Okada H, Imai H, Shirakami Y, Ohnishi K, Sugie S, Aoki H, Hatano Y, Noguchi K, Kanayama T, Niwa A, Suzui N, Miyazaki T, Tanaka T, Akiyama H, Shimizu M, Yoshida K, Hara A. | 01/29/2022 |
| Association study of fibroblast growth factor 10 (FGF10) rs399501 polymorphism with susceptibility to high myopia in a Chinese population. | Association study of fibroblast growth factor 10 (FGF10) rs399501 polymorphism with susceptibility to high myopia in a Chinese population.
Jiang X, Tong T, Xia N, Wu L, Zhang C, Zhang Y, Li RX. | 01/1/2022 |
| Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy. | Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
Jang SY, Choi SH, Kikkawa D, Lee EJ, Yoon JS., Free PMC Article | 11/27/2021 |
| Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects. | Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects.
Zhou S, Wang Q, Meng Z, Peng J, Zhou Y, Song W, Wang J, Chen S, Sun K., Free PMC Article | 07/3/2021 |
| FGF10 and FGF13 genetic variation and tooth-size discrepancies. | FGF10 and FGF13 genetic variation and tooth-size discrepancies.
Marañón-Vásquez GA, Vieira AR, Dos Santos LV, Cunha AS, Weiss SG, Araujo MTS, Bolognese AM, Scariot R, Küchler EC, Stuani MBS., Free PMC Article | 05/15/2021 |
| FGF8, FGF10 and FGF receptor 2 in foreskin of children with hypospadias: an analysis of immunohistochemical expression patterns and gene transcription. | FGF8, FGF10 and FGF receptor 2 in foreskin of children with hypospadias: an analysis of immunohistochemical expression patterns and gene transcription.
Haid B, Pechriggl E, Nägele F, Dudas J, Webersinke G, Rammer M, Fritsch H, Oswald J. | 03/6/2021 |
| Cytokine fibroblast growth factor 10 (FGF10) polymorphisms are associated with risk of myopia in young children. | Cytokine fibroblast growth factor 10 (FGF10) polymorphisms are associated with risk of myopia in young children.
Sun W, Li Y, Li J, Zhang X, Feng Q, Zhang Z, Kang J, Huang X. | 09/12/2020 |
| miR-145 promotes the EMT during the development of peritoneal fibrosis by suppressing FGF10 activity | MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10.
Wu J, Huang Q, Li P, Wang Y, Zheng C, Lei X, Li S, Gong W, Yin B, Luo C, Xiao J, Zhou W, Xu Z, Chen Y, Peng F, Long H., Free PMC Article | 06/13/2020 |
| Genetic polymorphisms in FGF3, FGF10, and FGF13 genes were associated with temporomandibular disorders in a population with dentofacial deformities | Polymorphisms in FGF3, FGF10, and FGF13 May Contribute to the Presence of Temporomandibular Disorders in Patients Who Required Orthognathic Surgery.
Carpio Horta K, Weiss SG, Miranda K, Sebastiani AM, Costa DJD, Matsumoto MAN, Marañón-Vásquez GA, Vieira AR, Scariot R, Küchler EC. | 11/30/2019 |
| Complex Compound Inheritance of Lethal Lung Developmental Disorders Due to Disruption of the TBX-FGF Pathway | Complex Compound Inheritance of Lethal Lung Developmental Disorders Due to Disruption of the TBX-FGF Pathway.
Karolak JA, Vincent M, Deutsch G, Gambin T, Cogné B, Pichon O, Vetrini F, Mefford HC, Dines JN, Golden-Grant K, Dipple K, Freed AS, Leppig KA, Dishop M, Mowat D, Bennetts B, Gifford AJ, Weber MA, Lee AF, Boerkoel CF, Bartell TM, Ward-Melver C, Besnard T, Petit F, Bache I, Tümer Z, Denis-Musquer M, Joubert M, Martinovic J, Bénéteau C, Molin A, Carles D, André G, Bieth E, Chassaing N, Devisme L, Chalabreysse L, Pasquier L, Secq V, Don M, Orsaria M, Missirian C, Mortreux J, Sanlaville D, Pons L, Küry S, Bézieau S, Liet JM, Joram N, Bihouée T, Scott DA, Brown CW, Scaglia F, Tsai AC, Grange DK, Phillips JA 3rd, Pfotenhauer JP, Jhangiani SN, Gonzaga-Jauregui CG, Chung WK, Schauer GM, Lipson MH, Mercer CL, van Haeringen A, Liu Q, Popek E, Coban Akdemir ZH, Lupski JR, Szafranski P, Isidor B, Le Caignec C, Stankiewicz P., Free PMC Article | 11/23/2019 |
| We report the ophthalmological and genetic study of a 19-year-old woman and her relatives suffering from this syndrome. A new probably pathogenic variant is described in the FGF10 gene. | New pathogenic variant in the FGF10 gene in the agenesis of lacrimal and salivary gland syndrome: Ophthalmological and genetic study.
Rodrigo MJ, Idoipe M, Izquierdo S, Satue M, Mateo A, Sanchez A, Garcia-Martin E, Pablo L. | 03/31/2018 |
| We have revealed significant association of FGFR2 and MAP3K1 polymorphisms with breast cancer. | Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z, Zubor P, Grendar M, Kapinova A, Zelinova K, Jagelkova M, Gondova A, Dokus K, Kalman M, Lasabova Z, Danko J. | 02/24/2018 |
| These results indicated that FGF-2, but not FGF-10, may be supplemented during stem cell expansion to prime cells for successful chondrogenesis and osteogenesis. | Fibroblast Growth Factor Ligand Dependent Proliferation and Chondrogenic Differentiation of Synovium-Derived Stem Cells and Concomitant Adaptation of Wnt/Mitogen-Activated Protein Kinase Signals.
Pizzute T, Li J, Zhang Y, Davis ME, Pei M., Free PMC Article | 11/25/2017 |
| The present data indicate that non-natural FGFR2 ligands, such as FGF10 and FGF19, are important factors in the pathophysiology of Aspert syndrome. | Cell Type-Dependent Nonspecific Fibroblast Growth Factor Signaling in Apert Syndrome.
Yeh E, Atique R, Fanganiello RD, Sunaga DY, Ishiy FA, Passos-Bueno MR. | 09/16/2017 |
| data suggest that the strongest signal of association at 5p12 is mediated through coordinated activation of FGF10 and MRPS30, two candidate genes for breast cancer pathogenesis | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, Kaufmann S, Sivakumaran H, Moradi Marjaneh M, Lee JS, Dennis J, Bolla MK, Wang Q, Dicks E, Milne RL, Hopper JL, Southey MC, Schmidt MK, Broeks A, Muir K, Lophatananon A, Fasching PA, Beckmann MW, Fletcher O, Johnson N, Sawyer EJ, Tomlinson I, Burwinkel B, Marme F, Guénel P, Truong T, Bojesen SE, Flyger H, Benitez J, González-Neira A, Alonso MR, Pita G, Neuhausen SL, Anton-Culver H, Brenner H, Arndt V, Meindl A, Schmutzler RK, Brauch H, Hamann U, Tessier DC, Vincent D, Nevanlinna H, Khan S, Matsuo K, Ito H, Dörk T, Bogdanova NV, Lindblom A, Margolin S, Mannermaa A, Kosma VM, kConFab/AOCS Investigators, Wu AH, Van Den Berg D, Lambrechts D, Floris G, Chang-Claude J, Rudolph A, Radice P, Barile M, Couch FJ, Hallberg E, Giles GG, Haiman CA, Le Marchand L, Goldberg MS, Teo SH, Yip CH, Borresen-Dale AL, NBCS Collaborators, Zheng W, Cai Q, Winqvist R, Pylkäs K, Andrulis IL, Devilee P, Tollenaar RA, García-Closas M, Figueroa J, Hall P, Czene K, Brand JS, Darabi H, Eriksson M, Hooning MJ, Koppert LB, Li J, Shu XO, Zheng Y, Cox A, Cross SS, Shah M, Rhenius V, Choi JY, Kang D, Hartman M, Chia KS, Kabisch M, Torres D, Luccarini C, Conroy DM, Jakubowska A, Lubinski J, Sangrajrang S, Brennan P, Olswold C, Slager S, Shen CY, Hou MF, Swerdlow A, Schoemaker MJ, Simard J, Pharoah PD, Kristensen V, Chenevix-Trench G, Easton DF, Dunning AM, Edwards SL., Free PMC Article | 05/27/2017 |
| Fgf10 signaling has an essential role in the formation of lipofibroblasts during late lung development | Evidence for the involvement of fibroblast growth factor 10 in lipofibroblast formation during embryonic lung development.
Al Alam D, El Agha E, Sakurai R, Kheirollahi V, Moiseenko A, Danopoulos S, Shrestha A, Schmoldt C, Quantius J, Herold S, Chao CM, Tiozzo C, De Langhe S, Plikus MV, Thornton M, Grubbs B, Minoo P, Rehan VK, Bellusci S., Free PMC Article | 05/28/2016 |
| Expression of Fibroblast Growth Factor 10 is correlated with poor prognosis in gastric adenocarcinoma. | Expression of Fibroblast Growth Factor 10 Is Correlated with Poor Prognosis in Gastric Adenocarcinoma.
Sun Q, Lin P, Zhang J, Li X, Yang L, Huang J, Zhou Z, Liu P, Liu N. | 03/26/2016 |
| FGF10 has a role in protecting neuron against oxygen-glucose deprivation injury through inducing heme oxygenase-1 | Fibroblast growth factor 10 protects neuron against oxygen-glucose deprivation injury through inducing heme oxygenase-1.
Li YH, Yang LY, Chen W, Li YK, Yuan HB. | 03/21/2015 |